A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial
- 1 July 2007
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 370 (9583), 240-250
- https://doi.org/10.1016/s0140-6736(07)61126-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangementLeukemia, 2007
- Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology GroupBlood, 2006
- Towards targeted therapy for infant acute lymphoblastic leukaemiaBritish Journal of Haematology, 2006
- Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trialsLeukemia, 2005
- Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantationBlood, 2004
- Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemiaBlood, 2002
- Intensive Alternating Drug Pairs After Remission Induction for Treatment of Infants With Acute Lymphoblastic LeukemiaJournal of Pediatric Hematology/Oncology, 1998
- Therapeutic Trial for Infant Acute Lymphoblastic Leukemia: The Pediatric Oncology Group Experience (POG 8493)Journal of Pediatric Hematology/Oncology, 1997
- Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells.JCI Insight, 1987
- Cytosine Arabinoside Influx and Nucleoside Transport Sites in Acute LeukemiaJCI Insight, 1982